# Hawaii Biotech, Inc.

Canonical: https://abierto.us/vendors/hawaii-biotech-inc-ecjkeefl4l51

- UEI: ECJKEEFL4L51
- CAGE: 0EAY9
- Location: Honolulu, HI
- Awards in window: 1 (4 transactions), -$1,407,283 obligated, March 8, 2024 to August 6, 2026

## Awarding agencies

- National Institutes of Health: 1 awards, -$1,407,283

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): -$1,407,283

## Competition

- Full and Open Competition: 1 awards

## Largest awards

- 75N93018C00023 (definitive contract): -$1,407,283, National Institutes of Health Niaid. To Develop a Small Molecule Drug Anti-Toxin Therapeutic to Treat Anthrax in Humans.. https://www.usaspending.gov/award/CONT_AWD_75N93018C00023_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/hawaii-biotech-inc-ecjkeefl4l51.